Daniel J. G. Thirion

591 total citations
28 papers, 227 citations indexed

About

Daniel J. G. Thirion is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Daniel J. G. Thirion has authored 28 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 9 papers in Infectious Diseases and 6 papers in Pharmacology. Recurrent topics in Daniel J. G. Thirion's work include Antibiotic Use and Resistance (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Patient Satisfaction in Healthcare (5 papers). Daniel J. G. Thirion is often cited by papers focused on Antibiotic Use and Resistance (6 papers), Antibiotics Pharmacokinetics and Efficacy (6 papers) and Patient Satisfaction in Healthcare (5 papers). Daniel J. G. Thirion collaborates with scholars based in Canada, Saudi Arabia and United States. Daniel J. G. Thirion's co-authors include Charles Frenette, Fahima Nekka, Bruce Dalton, Thomas A. Mavrakanas, L. E. Bergeron, Linda Dresser, Pierre‐Marie David, Marie‐Ève Tremblay, Marcelo Cantarovich and Tim T Y Lau and has published in prestigious journals such as SHILAP Revista de lepidopterología, BMC Public Health and Biomedicine & Pharmacotherapy.

In The Last Decade

Daniel J. G. Thirion

23 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel J. G. Thirion Canada 10 96 80 77 60 34 28 227
T. Fraisse France 9 93 1.0× 84 1.1× 67 0.9× 47 0.8× 18 0.5× 27 239
Scott Bergman United States 9 123 1.3× 60 0.8× 80 1.0× 81 1.4× 33 1.0× 42 276
Tina Khadem United States 9 49 0.5× 95 1.2× 65 0.8× 52 0.9× 52 1.5× 25 258
Caroline Chen Australia 9 62 0.6× 66 0.8× 125 1.6× 83 1.4× 22 0.6× 16 304
Athena L V Hobbs United States 10 129 1.3× 93 1.2× 121 1.6× 68 1.1× 47 1.4× 31 355
Nathalie Baillon-Plot France 8 65 0.7× 82 1.0× 60 0.8× 82 1.4× 34 1.0× 12 318
Angelina Davis United States 7 95 1.0× 52 0.7× 47 0.6× 105 1.8× 81 2.4× 18 242
Kristi Kuper United States 12 83 0.9× 89 1.1× 108 1.4× 131 2.2× 93 2.7× 29 340
Laura A. Liedtke United States 9 109 1.1× 124 1.6× 66 0.9× 100 1.7× 71 2.1× 12 313
Emily Mui United States 7 113 1.2× 154 1.9× 141 1.8× 59 1.0× 78 2.3× 18 300

Countries citing papers authored by Daniel J. G. Thirion

Since Specialization
Citations

This map shows the geographic impact of Daniel J. G. Thirion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel J. G. Thirion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel J. G. Thirion more than expected).

Fields of papers citing papers by Daniel J. G. Thirion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel J. G. Thirion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel J. G. Thirion. The network helps show where Daniel J. G. Thirion may publish in the future.

Co-authorship network of co-authors of Daniel J. G. Thirion

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel J. G. Thirion. A scholar is included among the top collaborators of Daniel J. G. Thirion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel J. G. Thirion. Daniel J. G. Thirion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thirion, Daniel J. G., et al.. (2025). Population Pharmacokinetic Model Evaluation with a Small Real-World Dataset Versus a Large Virtual Dataset: Does Sample Size Affect Decision-Making?. European Journal of Drug Metabolism and Pharmacokinetics. 50(5). 441–445.
2.
Frenette, Charles, Ian Schiller, Nandini Dendukuri, et al.. (2024). The changing epidemiology of Clostridioides difficile infection and the NAP1/027 strain in two Québec hospitals: a 17-year time-series study. SHILAP Revista de lepidopterología. 4(1). e99–e99. 2 indexed citations
3.
Thirion, Daniel J. G., et al.. (2024). Key stakeholder perspectives on delivery of vaccination services in Quebec community pharmacies. Canadian Pharmacists Journal / Revue des Pharmaciens du Canada. 157(6). 304–314. 1 indexed citations
4.
Thirion, Daniel J. G., et al.. (2023). Vaccine promotion strategies in community pharmacy addressing vulnerable populations: a scoping review. BMC Public Health. 23(1). 1855–1855. 8 indexed citations
5.
Thirion, Daniel J. G., et al.. (2022). Critical assessment of the revised guidelines for vancomycin therapeutic drug monitoring. Biomedicine & Pharmacotherapy. 155. 113777–113777. 8 indexed citations
6.
Thirion, Daniel J. G., et al.. (2022). New Recommendations of a Height-Based Dosing Regimen of Tobramycin for Cystic Fibrosis in Adults: A Population Pharmacokinetic Analysis. Therapeutic Drug Monitoring. 45(2). 251–258. 3 indexed citations
7.
Fortin, Élise, Daniel J. G. Thirion, Moussa Ouakki, et al.. (2021). Role of high-risk antibiotic use in incidence of health-care-associated Clostridioides difficile infection in Quebec, Canada: a population-level ecological study. The Lancet Microbe. 2(5). e182–e190. 5 indexed citations
8.
Frenette, Charles, Greg J. German, Kevin Afra, et al.. (2020). The 2017 global point prevalence survey of antimicrobial consumption and resistance in Canadian hospitals. Antimicrobial Resistance and Infection Control. 9(1). 104–104. 21 indexed citations
9.
Thirion, Daniel J. G., et al.. (2020). Amikacin nomogram for treatment of adult cystic fibrosis exacerbations based on an external evaluation of a population pharmacokinetic model. Pediatric Pulmonology. 55(5). 1154–1160. 6 indexed citations
10.
Lee, Stephen, et al.. (2019). Antimicrobial utilization data: Does point prevalence data correlate with defined daily doses?. Infection Control and Hospital Epidemiology. 40(8). 920–921. 4 indexed citations
11.
Morris, Andrew M., Elissa Rennert‐May, Nick Daneman, et al.. (2018). Rationale and development of a business case for antimicrobial stewardship programs in acute care hospital settings. Antimicrobial Resistance and Infection Control. 7(1). 104–104. 12 indexed citations
12.
Mavrakanas, Thomas A., et al.. (2017). Neutropenia in kidney and liver transplant recipients: Risk factors and outcomes. Clinical Transplantation. 31(10). 26 indexed citations
13.
Frenette, Charles, et al.. (2016). Impact of an Infection Control and Antimicrobial Stewardship Program on Solid Organ Transplantation and Hepatobiliary Surgical Site Infections. Infection Control and Hospital Epidemiology. 37(12). 1468–1474. 22 indexed citations
14.
Frenette, Charles, et al.. (2016). Influence of a 5-year serial infection control and antibiotic stewardship intervention on cardiac surgical site infections. American Journal of Infection Control. 44(9). 977–982. 10 indexed citations
15.
Thirion, Daniel J. G., et al.. (2012). Cost Comparison of Linezolid Versus Vancomycin for Treatment of Complicated Skin and Skin‐Structure Infection Caused by Methicillin‐Resistant Staphylococcus aureus in Quebec. Canadian Journal of Infectious Diseases and Medical Microbiology. 23(4). 187–195. 5 indexed citations
16.
Weiss, Karl, et al.. (2007). Clostridium difficile-associated diarrhoea rates and global antibiotic consumption in five Quebec institutions from 2001 to 2004. International Journal of Antimicrobial Agents. 30(4). 309–314. 14 indexed citations
17.
Nault, Vincent, et al.. (2007). Antimicrobial Stewardship in Acute Care Centres: A Survey of 68 Hospitals in Quebec. Canadian Journal of Infectious Diseases and Medical Microbiology. 19(3). 237–242. 12 indexed citations
18.
Thirion, Daniel J. G., et al.. (2006). Telithromycin‐Induced Digoxin Toxicity and Electrocardiographic Changes. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 26(6). 872–876. 4 indexed citations
19.
Thirion, Daniel J. G. & David Williamson. (2003). Les infections urinaires : une approche clinique. 36(5). 1 indexed citations
20.
Thirion, Daniel J. G., et al.. (2000). Potentiation of Warfarin's Hypoprothrombinemic Effect with Miconazole Vaginal Suppositories. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(1). 98–99. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by T. Fraisse Breakdown of academic impact, for papers by Scott Bergman Breakdown of academic impact, for papers by Tina Khadem Breakdown of academic impact, for papers by Caroline Chen Breakdown of academic impact, for papers by Athena L V Hobbs Breakdown of academic impact, for papers by Nathalie Baillon-Plot Breakdown of academic impact, for papers by Angelina Davis Breakdown of academic impact, for papers by Kristi Kuper Breakdown of academic impact, for papers by Laura A. Liedtke Breakdown of academic impact, for papers by Emily Mui
Rankless by CCL
2026